Skip to main content
  • About Us
  • Investors
  • Careers
  • Contact Us
Choose your market:
United States
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
    • Our history
    • Who we are
    • Key figures
    • Management
    • Values
    • Taking responsibility
    • The Path to Insights
    • Privacy & Data Collection
    • Online Data Quality Matters
    • Ipsos in the world
    • Media Resources
    • ISO Certification
  • Investors
  • Careers
    • Why Work at Ipsos
    • Opportunities at Ipsos
    • Professionals
    • Early Careers
    • Search Current Opportunities
    • The Path to Insights
  • Contact Us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 3223 results matching with your query. Refine by
  • Society

    Ipsos/Reuters Poll: Marijuana

    5 March 2015
  • Society

    Ipsos/Reuters Poll: Equal Pay

    5 March 2015
  • Society

    Ipsos/Reuters Poll (March 5): Core Political Approval

    5 March 2015
  • Society

    Ipsos/Reuters Poll: The Dress

    4 March 2015
  • Society

    Ipsos/Reuters Poll: Affordable Care Act

    4 March 2015
  • Society

    Ipsos/Reuters Poll: Climate Change

    26 February 2015
  • Society

    Ipsos/Reuters Poll: The Federal Reserve

    26 February 2015
  • Society

    Ipsos/Reuters Poll (February 26): Core Political Approval

    Washington, DC — President Obama's approval rate is coming back down after the bump in January and February.

    26 February 2015
  • Consumer & Shopper

    Direct-to-Consumer Pharmaceutical Advertising: When to Use Branded Versus Unbranded Campaigns

    For many pharmaceutical brands considering DTC, the pursuit of either a branded or unbranded campaign is a critical decision. The best approach can be determined by focusing on several specific factors: the extent to which patients with the disease remain undiagnosed, the amount of fair balance the product requires in a branded ad, and the current market share of the product.

    25 February 2015
  • Consumer & Shopper

    Is Hydrogen the Future of Automotive?

    When I was a kid, I thought by 2015 we would be flying around in cars like The Jetsons. It appears we aren't there just yet, despite my wish for us to be flying around by now! However, we have come a long way in powering vehicles.

    25 February 2015
Pagination
  • First page 1
  • Page 10 10
  • Page 100 100
  • Page 200 200
  • Page 220 220
  • Previous page <
  • Current page 228
  • Next page >
  • Page 240 240
  • Page 300 300
  • Last page 323

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • News & Events
  • Innovation & Knowledge
    • Consumer & Shopper
    • Corporate
    • Customer Experience
    • Entertainment
    • Media & Brand Communication
    • New Services
    • Society
  • OUR SOLUTIONS
    • Citizens
  • Citizens
  • Consumers & Brands
  • Capabilities
  • Doctors & Patients
  • Customers & Employees
  • About us
  • Contact Us
  • Press
  • Investors
  • Careers
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal Mentions
  • Privacy & Data Protection
  • Cookie Policy
  • Our Alert System